Physician profile
Mark M Crabbe
NPI 1619921905
$1,115.16
in general payments reported to CMS, 2019-2025
20 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $187 · 2021: $55.60 · 2022: $87.44 · 2023: $75.09 · 2024: $233 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $161.96 | 2024 | Irrisept |
| Novo Nordisk INC | $157.44 | 2019-2022 | |
| Smith+Nephew, INC. | $121.35 | 2019-2024 | Pico 14, Acticoat 4" X 4" |
| Genentech USA, INC. | $104.15 | 2020 | |
| Novartis Pharmaceuticals Corporation | $93.80 | 2019 | |
| Amgen INC. | $91.18 | 2019 | |
| Polynovo North America LLC | $68.06 | 2023-2025 | Novosorb Btm |
| Kerecis Limited | $59.11 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Tela Bio, INC. | $31.42 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $27.81 | 2025 | Phasix Mesh |
| Angiodynamics, INC. | $26.81 | 2025 | Smart Port Ct |
| Melinta Therapeutics, LLC | $26.70 | 2019 | |
| Merck Sharp & Dohme LLC | $26.03 | 2024 | Keytruda |
| Organogenesis INC. | $22.94 | 2021 | |
| Atricure, INC. | $20.98 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $19.10 | 2023 | Blastx, Xperience, Surgx |
| Abbvie INC. | $17.20 | 2021 | |
| Mallinckrodt Enterprises LLC | $15.89 | 2019 | |
| Advanced Oxygen Therapy INC. | $11.98 | 2022 | |
| Ekos Corporation | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Crabbe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.